A robust design for identification of the Parasite Clearance Estimator. by Jamsen, K, Duffull, S, Tarning, J, Price, R, Simpson, J

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria. by Jamsen, K, Duffull, S, Tarning, J, Lindegardh, N, White, N, Simpson, J

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria. by Jamsen, K, Duffull, S, Tarning, J, Lindegardh, N, White, N, Simpson, J

Towards optimal design of anti-malarial pharmacokinetic studies. by Simpson, J, Jamsen, K, Price, R, White, N, Lindegardh, N, Tarning, J, Duffull, S

Nonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparum by Simpson, J, Jamsen, K, Anderson, T, Zaloumis, S, Nair, S, Woodrow, C, White, N, Nosten, F, Price, R

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development by Zaloumis, S, Humberstone, A, Charman, S, Price, R, Moehrle, J, Gamo-Benito, J, McCaw, J, Jamsen, K, Smith, K, Simpson, J

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development. by Zaloumis, S, Humberstone, A, Charman, SA, Price, R, Moehrle, J, Gamo-Benito, J, McCaw, J, Jamsen, K, Smith, K, Simpson, J

Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. by Limmathurotsakul, D, Jamsen, K, Arayawichanont, A, Simpson, J, White, L, Lee, S, Wuthiekanun, V, Chantratita, N, Cheng, A, Day, N, Verzilli, C, Peacock, S